Ashley, D M; Sampson, J H; Archer, G E et al. (1998) Local production of TGF beta1 inhibits cerebral edema, enhances TNF-alpha induced apoptosis and improves survival in a murine glioma model. J Neuroimmunol 86:46-52
|
Ashley, D M; Kong, F M; Bigner, D D et al. (1998) Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res 58:302-9
|
Ashley, D M; Sampson, J H; Archer, G E et al. (1997) A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo. J Neuroimmunol 78:34-46
|
Liu, N P; Roberts, W L; Hale, L P et al. (1997) Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 38:2027-37
|
Ashley, D M; Faiola, B; Nair, S et al. (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177-82
|
Hale, L P; Haynes, B F; McCachren, S S (1995) Expression of CD44 variants in human inflammatory synovitis. J Clin Immunol 15:300-11
|
Hale, L P; Patel, D D; Clark, R E et al. (1995) Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. J Cutan Pathol 22:536-45
|